Clinical Trial Update: Shingles Prevention Study [Phase 3]

View source ↗

Summary

Phase 3 results from the Shingles Prevention Study have completed, evaluating a shingles vaccine for prevention of herpes zoster and postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Postherpetic Neuralgia

Drugs mentioned

• Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Herpes Zoster, Postherpetic Neuralgia | Phase 3 | Status: COMPLETED